SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-006577
Filing Date
2023-03-08
Accepted
2023-03-08 06:30:38
Documents
65
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nerv-20221231.htm   iXBRL 10-K 2915836
2 EX-4.2 nerv-ex4_2.htm EX-4 20189
3 EX-10.30 nerv-ex10_30.htm EX-10 34892
4 EX-23.1 nerv-ex23_1.htm EX-23 3644
5 EX-31.1 nerv-ex31_1.htm EX-31 16885
6 EX-31.2 nerv-ex31_2.htm EX-31 16494
7 EX-32.1 nerv-ex32_1.htm EX-32 13615
  Complete submission text file 0000950170-23-006577.txt   8539718

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nerv-20221231_cal.xml EX-101.CAL 44971
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nerv-20221231_def.xml EX-101.DEF 171568
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nerv-20221231.xsd EX-101.SCH 46155
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nerv-20221231_lab.xml EX-101.LAB 423064
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nerv-20221231_pre.xml EX-101.PRE 311388
59 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20221231_htm.xml XML 1307356
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36517 | Film No.: 23714820
SIC: 2834 Pharmaceutical Preparations